Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab
Sponsor: Christoph Königs
Summary
The goal of this observational study is to learn about the changes of antibodies and inhibitors against the coagulation factor VIII in patients with severe hemophilia A receiving emicizumab therapy. No additional visits or procedures are planned. Patients in this study will continue to receive their routine care and analysis will be done from left over samples from routine visits.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2023-04-26
Completion Date
2029-12
Last Updated
2023-07-10
Healthy Volunteers
No
Conditions
Interventions
no interventions
no intervention, only 3 different patients groups
Locations (1)
University Hospital Frankfurt, Goethe University
Frankfurt am Main, Hesse, Germany